126 related articles for article (PubMed ID: 17244784)
1. Increased adiposity enhances intrafollicular estradiol levels in normoandrogenic ovulatory women receiving gonadotropin-releasing hormone analog/recombinant human follicle-stimulating hormone therapy for in vitro fertilization.
Dumesic DA; Lesnick TG; Abbott DH
J Clin Endocrinol Metab; 2007 Apr; 92(4):1438-41. PubMed ID: 17244784
[TBL] [Abstract][Full Text] [Related]
2. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
[TBL] [Abstract][Full Text] [Related]
3. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.
Dumesic DA; Lesnick TG; Stassart JP; Ball GD; Wong A; Abbott DH
Fertil Steril; 2009 Jul; 92(1):217-21. PubMed ID: 18675414
[TBL] [Abstract][Full Text] [Related]
4. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
[TBL] [Abstract][Full Text] [Related]
5. Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization.
Dumesic DA; Schramm RD; Bird IM; Peterson E; Paprocki AM; Zhou R; Abbott DH
Biol Reprod; 2003 Oct; 69(4):1213-9. PubMed ID: 12801996
[TBL] [Abstract][Full Text] [Related]
6. Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Andersen AN; Loft A; Smitz J
J Clin Endocrinol Metab; 2014 Feb; 99(2):517-26. PubMed ID: 24297796
[TBL] [Abstract][Full Text] [Related]
7. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant follicle-stimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure.
Omodei U; Mazziotti G; Donarini G; Gola M; Guella V; Pagani F; Bugari G; Porcelli T; Giustina A
J Clin Endocrinol Metab; 2013 Jan; 98(1):330-6. PubMed ID: 23093489
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
10. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
[TBL] [Abstract][Full Text] [Related]
11. Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization.
Meden-Vrtovec H; Mocnik-Roznik S; Tomazevic T; Virant-Klun I
J Reprod Med; 2003 Oct; 48(10):799-803. PubMed ID: 14619648
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. Follicular fluid steroid levels in dysmature and mature follicles from spontaneous and hyperstimulated cycles in normal and anovulatory women.
Lobo RA; diZerega GS; Marrs RP
J Clin Endocrinol Metab; 1985 Jan; 60(1):81-7. PubMed ID: 3917271
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
16. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
17. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
Polan ML; Daniele A; Russell JB; DeCherney AH
J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
[TBL] [Abstract][Full Text] [Related]
18. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
Smitz J; Andersen AN; Devroey P; Arce JC;
Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
[TBL] [Abstract][Full Text] [Related]
20. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization.
Dumesic DA; Schramm RD; Peterson E; Paprocki AM; Zhou R; Abbott DH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1111-9. PubMed ID: 11889174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]